Department of Health Policy Archive — Page 15 of 16

Portrait of an older man in a dark suit, white shirt, and blue tie against a neutral background.
April 24, 2014

Schaffner honored by pharmacy association

William Schaffner, M.D., professor of Preventive Medicine at Vanderbilt University Medical Center, received the Immunization Champion Award — Friend of Pharmacy from the American Pharmacists Association (APA) at the group’s annual meeting recently in Orlando, Fla.

Child lying in bed with a blue cold pack on her forehead and a thermometer in her mouth, holding tissues beside her.
March 27, 2014

Flu boosts pneumococcal colonization

Influenza and parainfluenza infections – but not other respiratory viruses – increase the risk of acquiring pneumococcal bacteria, the most common cause of severe pneumonia.

Portrait of a smiling man wearing glasses, a dark suit, white shirt, and red tie.
February 20, 2014

Aliyu to receive preventive medicine ‘Rising Star’ award

Muktar Aliyu, M.D., associate professor of Health Policy and Medicine, is receiving the William Kane Rising Star Award from the American College of Preventive Medicine (ACPM) at its annual banquet on Saturday in New Orleans.

sick child
December 9, 2013

Penicillin equally effective as ‘big gun’ antibiotics for treating less severe childhood pneumonia, Vanderbilt study shows

Children hospitalized for pneumonia have similar outcomes, including length of stay and costs, regardless of whether they are treated with “big gun” antibiotics such as ceftriaxone or cefotaxime or more narrowly focused antibiotics such as ampicillin or penicillin.

stethoscope and money
October 17, 2013

Pharmacogenomic testing costs studied

A research team led by Josh Peterson, M.D., MPH, assistant professor of Biomedical Informatics and Medicine, and John Graves, Ph.D., assistant professor of Preventive Medicine, will study the cost-effectiveness of testing patients’ risk of adverse gene-drug interactions.

Assorted brightly colored capsules scattered on a white background.
August 22, 2013

Antipsychotic drug use in children for mood/behavior disorders increases type 2 diabetes risk

Prescribing “atypical” antipsychotic medications to children and young adults with behavioral problems or mood disorders may put them at unnecessary risk for type 2 diabetes, a Vanderbilt University Medical Center study shows.